Tory M Hagen

Prof. Dr. Tory M Hagen


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
KSKate Petersen Shay
Kate Petersen Shay
RMRegis Moreau
Regis Moreau
ESEric J. Smith
Eric J. Smith
ASAnthony R. Smith
Anthony R. Smith
THTory M Hagen
Tory M Hagen

11 April 2008 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
KSKate Petersen Shay
Kate Petersen Shay
RMRegis Moreau
Regis Moreau
ESEric J. Smith
Eric J. Smith
THTory M Hagen
Tory M Hagen

17 July 2013 in Annual Review of Nutrition
Verified
Journal Article
Closed access
AMAlexander J Michels
Alexander J Michels
THTory M Hagen
Tory M Hagen
BFBalz Frei
Balz Frei
New evidence for the regulation of vitamin C homeostasis has emerged from several studies of human genetic variation. Polymorphisms in the genes encoding sodium-dependent vitamin C transport proteins are strongly associated with plasma ascorbate levels and likely impact tissue cellular vitamin C status. Furthermore, genetic variants of proteins that suppress oxidative stress or detoxify oxidatively damaged biomolecules, i.e., haptoglobin, glutathione-S-transferases, and possibly manganese superoxide dismutase, affect ascorbate levels in the human body. There also is limited evidence for a role of glucose transport proteins. In this review, we examine the extent of the variation in these genes, their impact on vitamin C status, and their potential role in altering chronic disease risk. We conclude that future epidemiological studies should take into account genetic variation in order to successfully determine the role of vitamin C nutriture or supplementation in human vitamin C status and chronic disease risk.

1 October 2009 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
LGLuis A. Gómez
Luis A. Gómez
JMJeffrey S. Monette
Jeffrey S. Monette
JCJuan D. Chavez
Juan D. Chavez
CMClaudia Maier
Claudia Maier
THTory M Hagen
Tory M Hagen

1 June 2012 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
KSKate Petersen Shay
Kate Petersen Shay
AMAlexander J Michels
Alexander J Michels
WLWenge Li
Wenge Li
AKAh-Ng Tony Kong
Ah-Ng Tony Kong
THTory M Hagen
Tory M Hagen

1 May 2008 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Brian DixonBrian Dixon
Brian Dixon
SHShi-Hua D. Heath
Shi-Hua D. Heath
RKRobert Kim
Robert Kim
JSJung H. Suh
Jung H. Suh
THTory M Hagen
Tory M Hagen
Glutathione (GSH) and glutathione disulfide (GSSG) form the principal thiol redox couple in the endoplasmic reticulum (ER); however, few studies have attempted to quantify GSH redox status in this organelle. To address this gap, GSH and GSSG levels and the extent of protein glutathionylation were analyzed in rat liver microsomes. Because of the likelihood of artifactual GSH oxidation during the lengthy microsomal isolation procedure, iodoacetic acid (IAA) was used to preserve the physiological thiol redox state. Non-IAA-treated microsomes exhibited a GSH:GSSG ratio between 0.7:1 to 1.2:1 compared to IAA-treated microsomes that yielded a GSH:GSSG redox ratio between 4.7:1 and 5.5:1. The majority of artifactual oxidation occurred within the first 2 h of isolation. Thus, the ER GSH redox ratio is subject to extensive ex vivo oxidation and when controlled, the microsomal GSH redox state is significantly higher than previously believed. Moreover, in vitro studies showed that PDI reductase activity was markedly increased at this higher thiol redox ratio versus previously reported GSH:GSSG ratios for the ER. Lastly, we show by both HPLC and Western blot analysis that ER proteins are highly resistant to glutathionylation. Together, these results may necessitate a re-evaluation of GSH and its role in ER function.